what is bitcoin all about Top Overview

Shibor reported 1.4700% overnight, down 4.6 basis points; In 7 days, shibor reported 1.7840%, up 4.8 basis points; In three months, shibor reported 1.7480%, down 0.5 basis point.Market news: the largest political group in the European Union is pushing to weaken the ban on internal combustion engines.1 trillion yuan of ultra-long-term special government bonds have been arranged! The combination of boxing has been effective. At present, the "double"+"two new" annual 1 trillion yuan ultra-long-term special national debt has all been arranged. In November, the purchasing managers' index of manufacturing industry reached 50.3%, rising for three consecutive months. The "two-fold" and "two innovations" package of incremental policies is effectively promoting the sustained and steady progress of the economy. (CCTV News)

President Lukashenko of Belarus: There are about 30 locations in Belarus where Oreshnik missiles can be deployed.China's annual export rate in November was 5.8%, the previous value was 11.20%. China's annual import rate in November was -4.7%, while the previous value was -3.70%.Shengquan Group: It plans to buy back shares at a price of 250 million yuan to 500 million yuan. Shengquan Group announced that it plans to buy back shares by centralized bidding, and the estimated repurchase amount is 250 million yuan to 500 million yuan. The sources of funds are self-owned funds and special loans for stock repurchase. The repurchase price does not exceed 32 yuan/share, and the repurchased shares will be used for employee stock ownership plan or equity incentive. The repurchase period is 12 months from the date when the board of directors deliberated and approved this repurchase plan. The controlling shareholder, actual controller and Dong Jiangao of the company have no plans to reduce their holdings in the next 3 months and 6 months.

AstraZeneca's potential blockbuster ADC was recognized by the FDA. AstraZeneca and Thirteen announced that the FDA granted its Trop2 targeted antibody-coupled drug (ADC) Datopotamab Deruxtecan (Dato-DXD) breakthrough therapy recognition (BTD) to treat adult patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) who are undergoing treatment.China's annual export rate in November was 5.8%, the previous value was 11.20%. China's annual import rate in November was -4.7%, while the previous value was -3.70%.Malaya Investment Bank: The economies of many ASEAN countries are expected to maintain growth in 2025. The Malaya Investment Bank released a report on the 10th, showing that in 2025, the economies of ASEAN countries still have growth resilience and potential, despite the risk factors such as the shift of US economic policy, the increasing global trade tension and inflationary pressure. The report predicts that in 2025, the gross domestic product (GDP) of six ASEAN countries, namely Malaysia, Indonesia, the Philippines, Singapore, Thailand and Vietnam, will maintain an economic growth rate of 4.7%. (Xinhua News Agency)